Kribbs N B, Pack A I, Kline L R, Getsy J E, Schuett J S, Henry J N, Maislin G, Dinges D F
Center for Sleep and Respiratory Neurobiology, University of Pennsylvania School of Medicine, Philadelphia.
Am Rev Respir Dis. 1993 May;147(5):1162-8. doi: 10.1164/ajrccm/147.5.1162.
Nasal continuous positive airway pressure (CPAP) has become the nonsurgical treatment of choice for obstructive sleep apnea syndrome (OSAS). Recent evidence suggests that intermittent use of CPAP by patients is more common than nightly compliance. To determine the consequences of intermittent CPAP use, in terms of a return of sleep-disordered breathing and daytime hypersomnolence, 15 OSAS subjects were evaluated at three times: (1) before CPAP treatment (pretreatment), (2) after 30 to 237 days posttreatment during a night of CPAP use (on CPAP), and (3) during a night without CPAP (off CPAP). Evaluations of sleep-disordered breathing and three domains of hypersomnolence, physiologic sleep tendency, subjective sleepiness, and performance, were accomplished with the respiratory disturbance index (RDI), multiple sleep latency test (MSLT), Stanford sleepiness scale (SSS), and psychomotor vigilance task (PVT), respectively. CPAP use was encouraged and monitored from pretreatment to post-treatment by daily diaries for most subjects and an electronic device for a subset of subjects. As expected, CPAP eliminated apneas and hypopneas, and following the on CPAP night, there were statistically significant improvements in objective measures of sleepiness (MSLT and PVT). Subjective measures of sleepiness and fatigue also showed improvement. Sleeping without CPAP for one night reversed virtually all of the sleep and daytime alertness gains derived from sleeping with CPAP. This occurred despite a statistically significant reduction in the RDI on the night off CPAP (M = 36.8, SD = 28.0 events/h) relative to the pretreatment night (M = 56.6, SD = 24.8 events/h), which may be due to a lessening of the edema of the upper airway following CPAP use.(ABSTRACT TRUNCATED AT 250 WORDS)
鼻持续气道正压通气(CPAP)已成为阻塞性睡眠呼吸暂停低通气综合征(OSAS)的非手术首选治疗方法。最近的证据表明,患者间歇性使用CPAP比每晚持续依从使用更为常见。为了确定间歇性使用CPAP在睡眠呼吸紊乱复发和白天嗜睡方面的后果,对15名OSAS受试者进行了三次评估:(1)CPAP治疗前(治疗前),(2)治疗后30至237天在使用CPAP的一晚期间(使用CPAP时),以及(3)在不使用CPAP的一晚期间(停用CPAP时)。分别通过呼吸紊乱指数(RDI)、多次睡眠潜伏期试验(MSLT)、斯坦福嗜睡量表(SSS)和精神运动警觉任务(PVT)对睡眠呼吸紊乱和嗜睡的三个方面进行评估,即生理睡眠倾向、主观嗜睡和表现。对于大多数受试者,从治疗前到治疗后,通过每日日记鼓励并监测CPAP的使用情况,对于一部分受试者则使用电子设备进行监测。正如预期的那样,CPAP消除了呼吸暂停和呼吸不足,在使用CPAP的当晚之后,嗜睡的客观指标(MSLT和PVT)有统计学上的显著改善。嗜睡和疲劳的主观指标也有所改善。停用CPAP一晚几乎抵消了使用CPAP睡眠所带来的所有睡眠和白天警觉性的改善。尽管在停用CPAP当晚的RDI相对于治疗前一晚有统计学上的显著降低(M = 36.8,SD = 28.0次/小时)(治疗前一晚M = 56.6,SD = 24.8次/小时),但这种情况仍发生了,这可能是由于使用CPAP后上气道水肿减轻所致。(摘要截短于250字)